Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,161 to 2,180 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polyphosphates and Complement Activation. | Front Med (Lausanne) | 2019 | 31019911 | PubTator, text mining | PubMed |
| Novel Insights on Systemic and Brain Aging, Stroke, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease. | Aging Dis | 2019 | 31011489 | PubTator, text mining | PubMed |
| Significance of Complement System in Ischemic Stroke: A Comprehensive Review. | Aging Dis | 2019 | 31011487 | PubTator, text mining | PubMed |
| Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children. | Pediatr Allergy Immunol | 2019 | 30993784 | PubTator, text mining | PubMed |
| Melkersson⁻Rosenthal Syndrome in Childhood: Report of Three Paediatric Cases and a Review of the Literature. | Int J Environ Res Public Health | 2019 | 30974872 | PubTator, text mining | PubMed |
| Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55. | J Control Release | 2019 | 30974134 | PubTator, text mining | PubMed |
| Altered gene expression in antipsychotic-induced weight gain. | NPJ Schizophr | 2019 | 30971689 | PubTator, text mining | PubMed |
| A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema. | Pediatr Allergy Immunol | 2019 | 30968444 | PubTator, text mining | PubMed |
| Brain Death Enhances Activation of the Innate Immune System and Leads to Reduced Renal Metabolic Gene Expression. | Transplantation | 2019 | 30964836 | PubTator, text mining | PubMed |
| The therapeutic challenge of late antibody-mediated kidney allograft rejection. | Transpl Int | 2019 | 30955215 | PubTator, text mining | PubMed |
| Embryonic stem cell- and transcriptomics-based in vitro analyses reveal that bisphenols A, F and S have similar and very complex potential developmental toxicities. | Ecotoxicol Environ Saf | 2019 | 30951980 | PubTator, text mining | PubMed |
| Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction. | Front Immunol | 2019 | 30949180 | PubTator, text mining | PubMed |
| Update on C1 Esterase Inhibitor in Human Solid Organ Transplantation. | Transplantation | 2019 | 30946220 | PubTator, text mining | PubMed |
| Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses. | Front Immunol | 2019 | 30941119 | PubTator, text mining | PubMed |
| Identification and Mapping of a 2,009-bp DNA Deletion in SERPING1 of a Hereditary Angioedema Patient. | Case Rep Genet | 2019 | 30923640 | PubTator, text mining | PubMed |
| Single nucleotide polymorphisms in candidate genes are significantly associated with resistance to Haemonchus contortus infection in goats. | J Anim Sci Biotechnol | 2019 | 30918657 | PubTator, text mining | PubMed |
| Hereditary Angioedema Type 1 with Recurrent Dizziness. | Intern Med | 2019 | 30918175 | PubTator, text mining | PubMed |
| Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks. | Allergy Asthma Clin Immunol | 2019 | 30899278 | PubTator, text mining | PubMed |
| Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor. | Int Arch Allergy Immunol | 2019 | 30893690 | PubTator, text mining | PubMed |
| A Genetic Variant in GPR126 Causing a Decreased Inclusion of Exon 6 Is Associated with Cartilage Development in Adolescent Idiopathic Scoliosis Population. | Biomed Res Int | 2019 | 30886859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=109